Phosphanyltriazines as Ligands for Catalysts
1
2
6.5 Hz, 4 H, -CH2-CH2-CH2-), 2.67 (t, J = 7.7 Hz, 4 H, -CH2-Ph),
4.25 (t, J = 6.5 Hz, 4 H, -CH2-O), 7.12–7.28 (m, 10 H, arom.),
(d, JC,P = 6.5 Hz, 4 C, ipso-C), 134.8 (d, JC,P = 19.8 Hz, 8 C,
3
ortho-C), 163.3 (t, JC,P = 7.8 Hz, 1 C, triazine-6), 184.5 (dt, JC,P
7.30–7.37 (m, 6 H, arom.), 7.51–7.56 (m, 4 H, arom.) ppm. 13C{1H} = 11.2, 7.0 Hz, 2 C, triazine-2,4) ppm. 31P{1H} NMR (162 MHz,
NMR (100 MHz, CDCl3, 25 °C): δ = 30.1 (2 C, -CH2-CH2-CH2-), CDCl3, 25 °C): δ = 0.35 ppm. FABMS: 465 [M + H]+.
32.0 (2 C, -CH2-Ph), 67.6 (2 C, -CH2-O), 126.1 (s, 2 C, -CH2-Ph:
2,4-Bis(diphenylphosphanyl)-6-[(R)-1-phenylethylamino]-1,3,5-tri-
3
para-C), 128.44 (d, JC,P = 8.8 Hz, 4 C, P-Ph: meta-C), 128.48 (s,
azine (5d): 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.33 (d, J =
8 C, -CH2-Ph: ortho, meta-C), 129.5 (s, 2 C, -P-Ph: para-C), 133.7
7.2 Hz, 3 H, -CH3), 4.86 (quintet, J = 7.2 Hz, 1 H, CH), 5.52 (br.
1
2
(d, JC,P = 5.6 Hz, 2 C, -P-Ph: ipso-C), 134.9 (d, JC,P = 20.0 Hz, 4
d, J = 8 Hz, 1 H, NH), 7.02 (dd, J = 5.6, 1.6 Hz, 2 H, arom.),
7.18–7.45 (m, 23 H, arom.) ppm. 13C{1H} NMR (100 MHz,
CDCl3, 25 °C): δ = 21.9 (1 C, -CH3), 50.0 (1 C, CH), 126.1 (s, 2 C,
phenethyl-ortho-C), 127.1 (s, 1 C, phenethyl-para-C), 128.00 (d,
3JC,P = 14.0 Hz, 2 C, meta-C), 128.06 (d, 3JC,P = 6.9 Hz, 4 C, meta-
C), 128.2 (s, 2 C, para-C), 128.4 (s, 2 C, phenethyl-meta-C), 128.8
3
C, P-Ph: ortho-C), 141.2 (s, 2 C, -CH2-Ph: ipso-C), 170.8 (d, JC,P
1
= 7.7 Hz, 2 C, Tiazine-4,6), 190.1 (d, JC,P = 5.7 Hz, 1 C, triazine-
2) ppm. 31P{1H} NMR (162 MHz, CDCl3, 25 °C): δ = 2.46 ppm.
FABMS: 534 [M + H]+.
2-(Diphenylphosphanyl)-4-morpholino-6-(2-phenylethoxy)-1,3,5-tri-
azine (4i): 1H NMR (400 MHz, CDCl3, 25 °C): δ = 2.96 (t, J =
7.6 Hz, 2 H, -CH2-Ph), 3.55–3.85 (br., 8 H, -N-CH2-CH2-O-), 4.40
(t, J = 7.6 Hz, 2 H, PhCH2-CH2-O), 7.08–7.29 (m, 5 H, arom.),
7.30–7.37 (m, 6 H, arom.), 7.51–7.57 (m, 4 H, arom.) ppm. 13C{1H}
NMR (100 MHz, CDCl3, 25 °C): δ = 35.2 (1 C, -O-CH2-CH2-Ph),
43.5 (1 C, -CH2-N-), 43.9 (1 C, -CH2-N-), 66.58 (1 C, -NCH2-CH2-
O-), 66.63 (1 C, -NCH2-CH2-O-), 67.8 (1 C, PhCH2-CH2-O-), 126.5
2
(d, JC,P = 12.5 Hz, 2 C, meta-C), 129.0 (s, 2 C, para-C), 134.2 (d,
1JC,P = 6.0 Hz, 3 C, ipso-C), 134.3 (d, JC,P = 7.3 Hz, 1 C, ipso-C),
1
134.6 (d, 2JC,P = 18.8 Hz, 2 C, ortho-C), 134.75 (d, 1JC,P = 19.1 Hz,
1
2 C, ortho-C), 134.78 (d, JC,P = 19.9 Hz, 2 C, ortho-C), 134.9 (d,
1JC,P = 19.5 Hz, 2 C, ortho-C), 143.0 (s, 1 C, phenethyl-ipso-C),
3
161.4 (t, JC,P = 6.5 Hz, 1 C, triazine-6), 183.4 (dd, JC,P = 7.6,
6.2 Hz, 1 C, triazine-2/4), 184.3 (dd, JC,P = 8.2, 5.0 Hz, 1 C, tri-
azine-2/4) ppm. 31P{1H} NMR (162 MHz, CDCl3, 25 °C): δ = 0.58,
0.05 ppm. FABMS: 569 [M + H]+.
3
(s, 1 C, -CH2-Ph: para-C), 128.2 (d, JC,P = 7.8 Hz, 4 C, P-Ph:
meta-C), 128.5 (s, 2 C, -CH2-Ph: meta-C), 129.0 (s, 2 C, -CH2-Ph:
1
ortho-C), 129.2 (s, 2 C, -P-Ph: para-C), 134.5 (d, JC,P = 6.2 Hz, 2
2,4-Bis(diphenylphosphanyl)-6-methoxy-1,3,5-triazine (5e): 1H
NMR (400 MHz, CDCl3, 25 °C): δ = 3.74 (s, 3 H, -OCH3), 7.24–
7.48 (m, 20 H, arom.) ppm. 13C{1H} NMR (100 MHz, CDCl3,
25 °C): δ = 54.7 (1 C, -O-CH3), 128.2 (d, 3JC,P = 8.1 Hz, 8 C, meta-
2
C, -P-Ph: ipso-C), 134.9 (d, JC,P = 19.7 Hz, 4 C, P-Ph: ortho-C),
3
137.6 (s, 1 C, -CH2-Ph: ipso-C), 164.5 (d, JC,P = 7.5 Hz, 1 C, tri-
3
1
azine-4), 169.2 (d, JC,P = 8.9 Hz, 1 C, triazine-6), 186.6 (d, JC,P
= 11.1 Hz, 1 C, triazine-2) ppm. 31P{1H} NMR: δ = 1.02 ppm.
FABMS: 471 [M + H]+.
1
C), 129.1 (s, 4 C, para-C), 133.4 (d, JC,P = 5.7 Hz, 4 C, ipso-C),
2
3
134.7 (d, JC,P = 19.9 Hz, 8 C, ortho-C), 167.4 (t, JC,P = 6.3 Hz, 1
C, triazine-6), 187.2 (dd, JC,P = 4.2, 2.9 Hz, 2 C, triazine-2,4) ppm.
31P{1H} NMR (162 MHz, CDCl3, 25 °C): δ = 1.83 ppm. FABMS:
480 [M + H]+.
6-(PEG-600)-Substituted 2-(Diphenylphosphanyl)-4-morpholino-
1
1,3,5-triazine (4j): H NMR (400 MHz, CDCl3, 25 °C): δ = 3.55–
3.82 (br., -N-CH2-CH2-O-, O-CH2-CH2-O-), 4.34 (br. t, 2 H, -OH),
7.24–7.58 (m, 10 H, arom.) ppm. 31P{1H} NMR (162 MHz,
CDCl3, 25 °C): δ = 0.89 ppm. FABMS: 895 [M]+ (n = 12).
2,4-Bis(diphenylphosphanyl)-6-(3-phenylpropyloxy)-1,3,5-triazine
(5f): 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.91 (tt, J = 8.0,
6.8 Hz, 2 H, -CH2CH2CH2-), 2.59 (t, J = 8.0 Hz, 2 H, -CH2Ph),
4.15 (t, J = 6.8 Hz, 2 H, -CH2-O), 7.08–7.46 (m, 25 H, arom.) ppm.
1
2,4-Bis(diphenylphosphanyl)-6-morpholino-1,3,5-triazine (5a): H
NMR (400 MHz, CDCl3, 25 °C): δ = 3.54 (br. s, 8 H, -N-CH2-
CH2-O-), 7.20–7.33 (m, 12 H, arom.), 7.42–7.47 (m, 8 H, arom.)
ppm. 13C{1H} NMR (100 MHz, CDCl3, 25 °C): δ = 43.1 (2 C,
-CH2-N-), 66.4 (2 C, -CH2-O-), 128.0 (d, 3JC,P = 7.8 Hz, 8 C, meta-
13C{1H} NMR (100 MHz, CDCl3, 25 °C):
δ = 29.9 (1 C,
-CH2CH2CH2-), 31.9 (1 C, -CH2-Ph), 67.4 (1 C, -O-CH2-), 125.9
(s, 1 C, -CH2-Ph: para-C), 128.3 (d, JC,P = 8.1 Hz, 8 C, P-Ph:
3
1
C), 128.8 (s, 4 C, para-C), 134.4 (d, JC,P = 6.7 Hz, 4 C, ipso-C),
meta-C), 128.4 (s, 4 C, -CH2-Ph: ortho, meta-C), 129.2 (s, 4 C, -P-
Ph: para-C), 134.6 (d, 1JC,P = 5.8 Hz, 4 C, -P-Ph: ipso-C), 134.8 (d,
2JC,P = 19.9 Hz, 8 C, P-Ph: ortho-C), 141.1 (s, 1 C, -CH2-Ph: ipso-
C), 167.2 (t, 3JC,P = 6.7 Hz, 1 C, triazine-6), 187.2 (t, JC,P = 4.0 Hz,
2 C, triazine-2,4) ppm. 31P{1H} NMR (162 MHz, CDCl3, 25 °C):
δ = 1.76 ppm. FABMS: 480 [M + H]+.
2
3
134.7 (d, JC,P = 19.5 Hz, 8 C, ortho-C), 160.7 (t, JC,P = 6.4 Hz, 1
C, triazine-6), 183.5 (dd, 1JC,P = 8.4, 5.5 Hz, 2 C, triazine-2,4) ppm.
31P{1H} NMR (162 MHz, CDCl3, 25 °C): δ = 0.18 ppm. FABMS:
535 [M + H]+.
1
6-(Butylamino)-2,4-bis(diphenylphosphanyl)-1,3,5-triazine (5b): H
NMR (400 MHz, [D6]DMSO, 25 °C): δ = 0.74 (t, J = 7.4 Hz, 3
H, -CH3), 1.08 (sextet, J = 7.6 Hz, 2 H, -CH2-CH3), 1.20–1.30 (m,
2 H, -CH2-CH2-CH2-), 2.97 (q, J = 6.7 Hz, 2 H, -N-CH2-), 7.28–
7.44 (m, 20 H, arom.), 8.01 (t, J = 6.0 Hz, 1 H, NH) ppm. 13C{1H}
NMR (100 MHz, [D6]DMSO, 25 °C): δ = 14.0 (1 C, -CH3), 19.9
(1 C, -CH2-CH3), 31.0 (1 C, -CH2-CH2-CH2-), 40.6 (1 C, N-CH2-
Procedure for the Preparation of the Pd-4a Complex:
PdCl2(CH3CN)2 (50 mg, 0.19 mmol) and phosphanyltriazine 4a
(0.52 mmol) were dissolved in THF (7.5 mL) at room temp. under
Ar. After the mixture was stirred for 1 h, it was concentrated in
vacuo. The yellow solid residue was then recrystallized from
CH2Cl2/Et2O to give the single crystal of the Pd-4a suitable for X-
ray analysis.
3
3
), 128.7 (d, JC,P = 7.7 Hz, 4 C, meta-C), 128.9 (d, JC,P = 7.9 Hz,
4 C, meta-C), 129.5 (s, 2 C, para-C), 129.6 (s, 2 C, para-C), 134.7
1
2
Procedure for the Preparation of the Pd-5c Complex:
PdCl2(CH3CN)2 (106 mg, 0.41 mmol) and diphosphanyltriazine 5c
(0.43 mmol) were dissolved in CH2Cl2 (10 mL) at room temp. un-
der Ar. After the mixture was stirred for 1 h, the precipitate formed
was collected by filtration. The yellow solid was then recrystallized
from DMF/Et2O to give the single crystal of the Pd-5c complex
suitable for X-ray analysis.
(d, JC,P = 6.2 Hz, 2 C, ipso-C), 134.87 (d, JC,P = 19.5 Hz, 4 C,
ortho-C), 134.98 (d, 1JC,P = 6.5 Hz, 2 C, ipso-C), 134.99 (d, 2JC,P
20.0 Hz, 4 C, ortho-C), 162.1 (t, JC,P = 7.6 Hz, 1 C, triazine-6),
=
3
182.6 (dd, JC,P = 6.3, 11.4 Hz, 1 C, triazine-2/4), 183.3 (dd, JC,P
=
4.9, 11.3 Hz, 1 C, triazine-2/4) ppm. 31P{1H} NMR (162 MHz,
[D6]DMSO, 25 °C): δ = –1.53, –1.41 ppm. FABMS: 521 [M + H]+.
1
6-Amino-2,4-bis(diphenylphosphanyl)-1,3,5-triazine (5c): H NMR
(400 MHz, CDCl3, 25 °C): δ = 5.42 (br., 2 H, NH2), 7.23–7.44 (m, Typical Procedure for the Mizorogi–Heck Reaction Using Pd-4a:
20 H, arom.) ppm. 13C{1H} NMR (100 MHz, CDCl3, 25 °C): δ =
Aryl halide (0.50 mmol), NaOAc (0.55 mmol), Pd(OAc)2
128.2 (d, 3JC,P = 8.0 Hz, 8 C, meta-C), 129.1 (s, 4 C, para-C), 134.1 (0.01 mmol, 2 mol-%) and phosphane ligand 4a (0.04 mmol, 8 mol-
6
Eur. J. Org. Chem. 2009, 4956–4962
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4961